Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kimberly Popovits Insider Profile
4 Followers
Kimberly Popovits, President & CEO, Director at Genomic Health, holds 0.00 shares in Genomic Health (Ticker: GHDX), holds 2.30K shares in MyoKardia (Ticker: MYOK), holds ― shares in Kiniksa Pharmaceuticals (Ticker: KNSA).
Kimberly Popovits Genomic Health (GHDX)President & CEO, Director
Genomic Health (GHDX)
President & CEO, Director
Ranked #5,764 out of 78,624 Corporate Insiders
Profitable Transactions
7 out of 13 Profitable Transactions
Average Return
+21.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Kimberly Popovits does not currently own shares as a corporate insider.
A breakdown of Kimberly Popovits's holdings
Insider Roles
Roles that Kimberly Popovits holds in companies
Most Profitable Insider Trade
Stock:
Genomic Health
(GHDX)
(GHDX)
Rating:Informative Buy
Date:Mar 16, 2018 - Mar 16, 2019
Return:+125.20%
The most profitable trade made by Kimberly Popovits
Kimberly Popovits's Trading History
Genomic Health
Nov 14, 2019
―
Uninformative Sell
―
$0.00
MyoKardia
―
―
―
$517.29K
Kiniksa Pharmaceuticals
―
Director
―
―
10x Genomics
―
Director
―
―
ZS Pharma
Dec 21, 2015
―
Uninformative Sell
90.00K
$0.00
Arca Biopharma
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Kimberly Popovits's performance on stock
You May Also Like
Kimberly Popovits insider profile FAQ
What is the percentage of profitable transactions made by Kimberly Popovits?
The percentage of profitable transactions made by Kimberly Popovits is 54%.
What is the average return per transaction made by Kimberly Popovits?
The average return per transaction made by Kimberly Popovits is 21.40%.
What stocks does Kimberly Popovits hold?
Kimberly Popovits holds: GHDX, MYOK, KNSA, TXG, ZSPH, ABIO stocks.
What was Kimberly Popovits’s latest transaction?
Kimberly Popovits latest transaction was an Uninformative Sell of ―.
What was Kimberly Popovits's most profitable transaction?
Kimberly Popovits’s most profitable transaction was an Informative Buy of GHDX stock on March 16, 2018. The return on the trade was 125.20%.
What is Kimberly Popovits's role in Genomic Health?
Kimberly Popovits's role in Genomic Health is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.